Stephan Dietrich A

CIK 0001774588

President and CEODirector10% Owner

Filings

Latest Aug 4, 2023

Issuers covered

Showing

5 of 5

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Stephan Dietrich A. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Stephan Dietrich A has filed

Ticker	Issuer	Filings	Last filed
NBSE	Neubase Therapeutics, Inc.	5	Aug 4, 2023

5 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Aug 4, 2023	NBSENeubase Therapeutics, Inc.	MExercise	93,234	$0.022	$2,051
Mar 17, 2023	NBSENeubase Therapeutics, Inc.	AGrant	153,000	$0.00	$0
Feb 15, 2023	NBSENeubase Therapeutics, Inc.	MExercise	655,000	$0.00	$0
Jan 25, 2022	NBSENeubase Therapeutics, Inc.	Holdings only	-	-	-
Jan 5, 2022	NBSENeubase Therapeutics, Inc.	MExercise	42,250	$0.001	$42

Showing 1-5 of 5

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.